Today: 13 June 2026
Micron Stock Price Edges Up Ahead of Earnings After Nvidia AI Memory Milestone
18 March 2026
2 mins read

Micron Stock Price Edges Up Ahead of Earnings After Nvidia AI Memory Milestone

New York, March 18, 2026, 10:50 EDT

Micron Technology traded up early Wednesday, the stock tacking on 0.3% to $463.01 as of 10:35 a.m. EDT, a day after rallying 4.5%. Traders pointed to Micron’s latest HBM win for Nvidia’s Vera Rubin systems, with the company’s quarterly results due after the bell.

This report is shaping up as a real test for whether the AI investment surge can actually change the fundamentals for a company that’s spent years riding brutal memory-chip cycles. According to FactSet consensus via MarketWatch, fiscal second-quarter adjusted earnings are pegged at $9.19 a share, with revenue just about $20 billion. Rosenblatt’s Kevin Cassidy called the setup a “slight beat-and-raise.” MarketWatch

Micron’s results send signals to rivals Samsung Electronics and SK Hynix, both key HBM suppliers—HBM being the high-speed memory that works alongside AI accelerators. On Wednesday, Samsung co-CEO Jun Young-hyun described the current market as an “unprecedented supercycle.” Over at SK Group, Chairman Chey Tae-won warned that wafer shortages linked to AI demand could persist through 2030. Reuters

On Monday, Micron announced its 36GB 12-layer HBM4 is now shipping in volume for Nvidia’s Vera Rubin platform. The chip delivers more than 2.8 terabytes per second of bandwidth and offers over 20% better power efficiency compared to HBM3E. “Scale together from day one,” said Sumit Sadana, Micron’s chief business officer, describing how the company is working with Nvidia to align compute and memory. Micron Technology

Earlier, the company took another step forward. According to Reuters, Micron is set to build a second fab at its recently acquired Tongluo site in Taiwan—bought from Powerchip Semiconductor. The goal: ramp up DRAM and HBM chip output. Construction’s slated to kick off before the close of fiscal 2026.

It’s a punishing environment for buyers now, while suppliers are reaping the rewards. In February, TrendForce projected that conventional DRAM contract prices would soar 90% to 95% in the January-March quarter compared to the previous period—AI and data-center appetite is fueling that surge, along with a sharper supply-demand imbalance.

Micron faces stiff competition. Back in December, Reuters noted that Micron’s HBM supply for 2026 was already spoken for, with tightness likely to persist even further out. Samsung, meanwhile, announced last month it began shipping HBM4 to clients, stepping up efforts to catch rivals.

The setup is a double-edged sword. According to Barron’s, Micron’s bigger presence in Taiwan could boost global memory supply by close to 20% through 2027-28, but that may not be enough to meet demand. There’s also a warning: pricier DRAM chips could squeeze margins for smartphone and PC makers. Wednesday brought some heat too—U.S. producer prices ran hotter, oil climbed again, yields moved higher, and the broader market grew less forgiving. If Micron’s guidance falls short, the shares could feel it.

Micron will report its fiscal second-quarter earnings after Wednesday’s close, with a conference call set for 2:30 p.m. Mountain time, according to a company notice. Investors are likely to focus as much on the outlook as on the top-line figures.

Stock Market Today

  • CSL Shares Rise 9.8% After FY26 Guidance Cut on Impairments and Channel Shifts
    June 13, 2026, 5:50 AM EDT. CSL (ASX:CSL) shares climbed 9.8% following a downward revision of its FY26 revenue and profit forecasts. The revision reflects impairments and writedowns linked to changes in U.S. immunoglobulin sales channels and weakening albumin prices in China. Despite these challenges, investor sentiment shows cautious optimism about CSL's operational turnaround prospects. The market now awaits CSL's full-year results and dividend update on 18 August 2026, which will offer clarity on revenue trends and any further impairments. CSL projects FY29 revenue of US$16.9 billion and earnings of US$3.3 billion, suggesting a potential 31% upside to current share prices. However, risks remain around sustained margin pressure and additional write-downs in plasma and albumin segments.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 13.06.2026

13 June 2026
LIVEMarkets rolling coverageStarted: June 13, 2026, 4:00 AM EDTUpdated: June 13, 2026, 6:10 AM EDT CSL Shares Rise 9.8% After FY26 Guidance Cut on Impairments and Channel Shifts June 13, 2026, 5:50 AM EDT. CSL (ASX:CSL) shares climbed 9.8% following a downward revision of its FY26 revenue and profit forecasts. The revision reflects impairments and writedowns linked to changes in U.S. immunoglobulin sales channels and weakening albumin prices in China. Despite these challenges, investor sentiment shows cautious optimism about CSL’s operational turnaround prospects. The market now awaits CSL’s full-year results and dividend update on 18 August 2026, which will offer
SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

13 June 2026
SGH closed at A$41.51, up 0.70% but underperformed the S&P/ASX 200’s 1.98% surge, as investors weighed solid cash flow and Boral margin gains against a high 36.03 P/E, mixed demand, and M&A risk; the next key catalyst is FY26 results on August 11, with analysts’ average target at A$47.64, 14.76% above Friday’s close.
Tesla Stock Price Today: Why TSLA Is Holding Near $400 After Samsung Chip News
Previous Story

Tesla Stock Price Today: Why TSLA Is Holding Near $400 After Samsung Chip News

Dow Jones Today: Hot PPI and Oil Spike Send Industrial Average Lower Ahead of Fed
Next Story

Dow Jones Today: Hot PPI and Oil Spike Send Industrial Average Lower Ahead of Fed

Go toTop